Reckitt Benckiser’s RKT1.44%increase; green up pointing triangle shares rose after the company said adjusted profit beat market expectations, despite lower sales, as it continues to progress with its ...

As trade war intensifies, Reckitt may be more exposed than some rivals Some investors fear Reckitt may be forced to raise its prices in the United States or face higher costs as its low ...

Health and Human Services Secretary Robert F. Kennedy Jr. is taking on baby formula products, the latest in his sweeping ...

Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as "non-core" in July as part of a ...

Reckitt Benckiser Group PLC closed 4.02% short of its 52-week high of £54.18, which the company reached on March 7th.

(Bloomberg) -- Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they ...

Berenberg analyst Fulvio Cazzol raised the firm’s price target on Reckitt Benckiser (RBGLY) to 5,920 GBp from 5,177 GBp and keeps a Hold rating ...

Reckitt Benckiser Group PLC closed 5.02% below its 52-week high of £54.18, which the company achieved on March 7th.

Kennedy held a discussion with the chief executives from Abbott Laboratories, which makes Similac, Enfamil maker Reckitt Benckiser Group ... Florida’s College of Medicine.